美国 · SEC FORM 4
Vanda Pharmaceuticals Inc.
VNDA · Nasdaq · CIK 0001347178 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
9 同一窗口内观察到的 Form 4 交易行
0 sales · 9 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-07 · Polymeropoulos Mihael Hristos.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,831,971
- 上期报告
- 8,495,290
- 日均成交量
- 1,213,899
- 回补天数
- 6.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-07 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.15 | USD 41,500 | SEC 申报 ↗ |
| 2025-05-21 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.40 | USD 43,995 | SEC 申报 ↗ |
| 2025-05-16 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 20,000 | USD 4.22 | USD 84,400 | SEC 申报 ↗ |
| 2025-03-06 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 5.01 | USD 50,150 | SEC 申报 ↗ |
| 2025-03-05 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 5.02 | USD 50,200 | SEC 申报 ↗ |
| 2025-03-03 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.71 | USD 47,100 | SEC 申报 ↗ |
| 2025-02-28 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.76 | USD 47,600 | SEC 申报 ↗ |
| 2025-02-27 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.76 | USD 47,600 | SEC 申报 ↗ |
| 2025-02-26 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.76 | USD 47,650 | SEC 申报 ↗ |
| 2025-02-25 | Polymeropoulos Mihael Hristos | 买入 (P) | Common Stock | 10,000 | USD 4.46 | USD 44,600 | SEC 申报 ↗ |
| 2025-02-21 | Moran Kevin Patrick | 买入 (P) | Common Stock | 2,000 | USD 4.39 | USD 8,780 | SEC 申报 ↗ |
Form 4 申报证据
20 transaction lines in the latest 365-day window; 221 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Ward Anne Sempowski | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Mitchell Stephen Ray | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | McGuire Daniel Patrick | 奖励／授予 (A) | Common Stock | 80,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (20 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Ward Anne Sempowski | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Mitchell Stephen Ray | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | McGuire Daniel Patrick | 奖励／授予 (A) | Common Stock | 80,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Honore Tage | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Duncan Charles Cliff | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | DUGAN RICHARD W | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Chrousos Phaedra | 奖励／授予 (A) | Common Stock | 41,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-18 | Mitchell Stephen Ray | 赠与 (G) | Common Stock | 25,836 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-22 | Duncan Charles Cliff | 奖励／授予 (A) | Common Stock | 57,101 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Williams Timothy | 卖出 (S) | Common Stock | 42,434 | USD 8.27 | USD 350,929 | SEC 申报 ↗ |
| 2026-03-02 | Wijkstrom Joakim | 卖出 (S) | Common Stock | 30,800 | USD 8.27 | USD 254,716 | SEC 申报 ↗ |
| 2026-03-02 | Polymeropoulos Mihael Hristos | 卖出 (S) | Common Stock | 156,235 | USD 8.17 | USD 1,276,440 | SEC 申报 ↗ |
| 2026-03-02 | Moran Kevin Patrick | 卖出 (S) | Common Stock | 42,442 | USD 8.27 | USD 350,995 | SEC 申报 ↗ |
| 2026-03-02 | Birznieks Gunther | 卖出 (S) | Common Stock | 42,431 | USD 8.27 | USD 350,904 | SEC 申报 ↗ |
| 2026-02-23 | Honore Tage | 卖出 (S) | Common Stock | 30,000 | USD 8.03 | USD 240,900 | SEC 申报 ↗ |
| 2026-02-18 | Williams Timothy | 奖励／授予 (A) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Wijkstrom Joakim | 奖励／授予 (A) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Polymeropoulos Mihael Hristos | 奖励／授予 (A) | Common Stock | 525,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Moran Kevin Patrick | 奖励／授予 (A) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Birznieks Gunther | 奖励／授予 (A) | Common Stock | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VNDA |
| CIK | 0001347178 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 221 transaction lines from 2020-01-02 to 2026-06-04 15 P purchase lines · 103 S sale lines · 103 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.